According to the report, the share capital increase will be carried out by issuing 398.6 million new shares with a nominal value of RON0.25 per unit and through the incorporation of share premiums and reserves (with the exception of the legal reserves).
The newly issued shares will be allocated free of charge to MedLife shareholders registered in the register of shareholders on September 4, 2023, set as the registration date.
“Each shareholder registered in the register of shareholders kept by Depozitarul Central – S.A. on the Record Date will receive 3 (three) newly issued shares, free of charge for each share held on the Record Date. The increase of the Share Capital will be carried out to support the current activity of the Company”, MedLife representatives said in the report.
The proposition for the ex date is September 9, 2023 and the actual payment date of the free shares is envisaged to be made on September 5, 2023.
M shares have gained 9.6% so far in 2023 and lost 6% over the last 12 months.
MedLife Group ended the first quarter of 2023 with a consolidated turnover worth RON529 million, up 26.4% on the year, supported by all the business lines of the group and the 2022 and 2023 acquisitions. Its net profit decreased from RON29.5 million to RON8.4 million.
The largest part of revenues, RON199 million, was generated by the clinic network, up 49% on the year, followed by hospitals, with RON108 million, up 26% on the year. Its operating profit fell by 32.5% on the year to RON27 million, as per data from the company’s quarterly report.